Moderna enters P3 trials for vaccine, with $483m BARDA push
US government supports Moderna’s clinical program for its COVID-19 vaccine with financial backing.
Archives for July 30, 2020
Kite gets second CAR-T approval, 96% manufacturing success rate
Kite becomes the first company to have two approved CAR-T treatments, with its second targeting rare form of lymphoma.